JSH, ENECHANGE, ETC.
<150A>Shareholding percentage of JSH Jafco Group Co., Ltd. stocks 26.06% → 24.89% Reporting obligation date 2025/02/05 <4169> Shareholding percentage of ENECHANGE Co., Ltd. stocks -% → 16.00% Reporting obligation date 2025/02/05 <7325> Shareholding percentage of IRRIC Corporation stocks -% → 6.51%.
Express News | [Change Report] JAFCO Group reports that its Shareholding in JSH (150A.JP) has decreased to 24.89%.
It seems strong and there is a strong desire to explore, but the upward movement might be heavy.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a stable development. In the US stock market on the 12th, the Dow Inc fell by $225.09 (-0.50%) to $44,368.56, marking a retreat after three days. As the Consumer Price Index (CPI) unexpectedly accelerated, expectations for interest rate cuts diminished, causing interest rates to rise, which weighed on stock prices. On the other hand, the Nasdaq saw an increase propelled by Intel (INTC) and Apple (AAPL), recovering into positive territory, while the major Index ETF closed mixed.
JSH: Notice regarding transition to consolidated financial results and consolidated earnings forecast for the fiscal year ending March 31, 2025
JSH: Presentation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
JSH: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
JSH, Orts [Emerging Markets 5% Rule]
<150A>JSH Jafco Group Inc. Shareholding ratio of Stocks 27.09% → 26.06% Reporting obligation start date 2025/01/29 <260A>Ortz Jafco Group Inc. Shareholding ratio of Stocks 5.24% → 4.24% Reporting obligation start date 2025/01/29
Express News | [Change Report] Jafco Group reports a decrease in their Shareholding in JSH (150A.JP) to 26.06%.
JSH, Rakusas Technologies.
<150A>JSH JaFco Group Inc. Shareholding ratio of stocks 28.18% → 27.09% Reporting obligation start date 2025/01/09<288A>Raksas Technologies Inc. Shareholding ratio of stocks 44.29% → 41.56% Reporting obligation start date 2025/01/09
Individual stock information.
Tameeni <6181.T> rebounds. The company has been selected for the Ministry of Economy, Trade and Industry's "Life Stage Support Service Implementation Demonstration Project". From mid-January onwards, life design seminars targeting young people in their 20s and 30s from companies and organizations will be held sequentially. Torasuon <6696.T> rebounds for the first time in four days. An order was received for STB (Set-Top Box) terminals and related software development projects. The order amount is 44 million yen (excluding tax), and the contract deadline is June (scheduled).
Express News | [Change Report] Jafco Group reports a decrease in the Shareholding of JSH (150A.JP) to 27.09%.
JSH --- 2Q revenue of 1.909 billion yen, promoting the strengthening of total solution sales and the expansion of sales channels in local revitalization projects.
On the 14th, JSH <150A> announced its financial results for the second quarter of the fiscal year ending March 2025 (April-September 2024). Revenue was 1.909 billion yen, operating profit was 0.08 billion yen, recurring profit was 0.087 billion yen, and interim net profit was 0.068 billion yen. For the interim period ending March 2024, no interim financial statements were prepared, so the year-on-year change rate for the interim period is not provided. Revenue from regional revitalization projects was 1.153 billion yen, and segment profit was 0.233 billion yen. During this interim accounting period,
JSH: Confirmation letter
JSH: Half Year Report - Term 9 (2024/04/01 - 2025/03/31)
JSH: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025
JSH: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Asahi, Matsukiyo, Dentsu Group, Lancers (14th) (1379-4990)
※The above calendar is merely a schedule and may be subject to change due to the company's circumstances. --------------------------------------- November 14 (Thursday) <1379> Hokuto <1380> Akikawa Bokuen <142A> Jinjibu <1438> Gifu Landscape <1443> Giken HD <1446> Candiule <1447> SAAF HD <145A> El
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
JSH--Significant rebound, opening a new base for home medical care business in Edogawa Ward, Tokyo.
Sharply rebounded. Selling took the lead in the morning, but later on, buying has become dominant. It has been announced that a new base for home medical care, the 'Visiting Nursing Station Cordiale Edo Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nursing Station Cordiale' is a psychiatric home visit support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, prompting area expansion.
JSH Research Memo (9): Prioritize the enhancement of internal reserves in the near term and continue with no dividends.
The shareholder return policy JSH <150A> positions shareholder return as one of the important management issues, however, as of the end of March 2024, the retained earnings are in a deficit of 4.32 billion yen. Therefore, it is necessary to continue with no dividends for the time being in order to enhance corporate value through the strengthening of retained earnings. While there is a high possibility that the retained earnings will turn positive by the end of March 2027, the policy is to determine the timing of dividend initiation comprehensively based on performance, financial situation, fund needs, etc. (Writing)